ACTINIUM PHARMACEUTICALS, INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, shares, new issues for the quarter ending 2015-12-31 was 4.58M shares.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, shares, new issues for the quarter ending 2015-09-30 was -1.56M shares.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, shares, new issues for the quarter ending 2015-06-30 was 2.61M shares.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, shares, new issues for the quarter ending 2015-03-31 was 500.00 shares, a 0.00% change year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. stock issued during period, shares, new issues for fiscal 2015 was 5.63M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2015-12-31 | 4.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | 5.63M shares 10-K · filed 2016-03-11 |
| 2015-09-30 | -1.56M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | |
| 2015-06-30 | 2.61M shares 10-Q · filed 2015-08-07 | |
| 2015-03-31 | 500.00 shares derived: 10-K 12 month − 3 quarters · filed 2016-03-11 | |
| 2014-04-28 | 500.00 shares 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |